Syensqo Acquires Azerys, a Natural Rosemary Extraction Company

Syensqo has completed the acquisition of a controlling stake in Azerys, a specialist in rosemary extraction with assets in El Jadida, Morocco.

Azerys produces a 100% natural plant-based, non-GMO preservative range of rosemary extract, which can replace traditional food additives, aligned with consumer demand for more natural food ingredients. This bolt-on acquisition complements Syensqo’s leading activities in natural vanillin produced from rice bran and allows the company to expand its capabilities in renewable consumer solutions.

Similar to other recent acquisitions, such as Jin Young Bio, it aligns with the strategic focus of Syensqo’s Renewable Materials and Biotechnology Growth Platform. 

"Natural preservatives are a growing segment in the bioeconomy and rosemary extract is a key product in food preservation, requested by customers in this space," commented Jo Grosemans, Head of Business Development for the Renewable Materials and Biotechnology Platform. "As the leading supplier of vanillin to the world, we have an excellent reputation of quality and service and we will bring the same values to this new field.”

“This acquisition serves the company’s mission to deliver sustainable, natural solutions and we are looking forward to exploring new possibilities through the power of green extraction technologies," added Ilham Kadri, CEO of Syensqo.

Azerys relies on a state-of the art facility and a strong network of local cooperatives supporting sustainable and responsible agriculture to recover high value components from rosemary. Syensqo will leverage its leading supply chain, innovation capabilities and global customer reach to accelerate the development of new product ranges aligned with its growth strategy.

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.